HomeCompareCGSD vs MRK

CGSD vs MRK: Dividend Comparison 2026

CGSD yields 4.49% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $30.0K in total portfolio value
10 years
CGSD
CGSD
● Live price
4.49%
Share price
$25.79
Annual div
$1.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.8K
Annual income
$598.33
Full CGSD calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CGSD vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCGSDMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CGSD + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CGSD pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CGSD
Annual income on $10K today (after 15% tax)
$381.47/yr
After 10yr DRIP, annual income (after tax)
$508.58/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $7,819.83/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CGSD + MRK for your $10,000?

CGSD: 50%MRK: 50%
100% MRK50/50100% CGSD
Portfolio after 10yr
$41.8K
Annual income
$5,198.24/yr
Blended yield
12.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CGSD
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CGSD buys
0
MRK buys
0
No recent congressional trades found for CGSD or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCGSDMRK
Forward yield4.49%2.76%
Annual dividend / share$1.16$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$26.8K$56.8K
Annual income after 10y$598.33$9,798.13
Total dividends collected$5.3K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CGSD vs MRK ($10,000, DRIP)

YearCGSD PortfolioCGSD Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,149$448.78$11,206$366.19$57.00MRK
2$12,397$467.61$12,650$502.35$253.00MRK
3$13,751$485.93$14,407$694.19$656.00MRK
4$15,217$503.74$16,585$967.82$1.4KMRK
5$16,803$520.98$19,342$1,363.89$2.5KMRK
6$18,517$537.65$22,913$1,947.19$4.4KMRK
7$20,367$553.73$27,662$2,823.89$7.3KMRK
8$22,362$569.21$34,159$4,173.35$11.8KMRK
9$24,511$584.07$43,337$6,308.80$18.8KMRK
10$26,825$598.33$56,776$9,798.13$30.0KMRK

CGSD vs MRK: Complete Analysis 2026

CGSDStock

The fund’s investment objective is to provide current income, consistent with a short duration profile as described in the prospectus and with the preservation of capital.Distinguishing Characteristics The fund will invest primarily in bonds (bonds include any debt instrument and cash equivalents, and may be represented by derivatives). The fund consists primarily of debt securities rated BBB- (or Baa3) or better by Nationally Recognized Statistical Rating Organizations designated by the fund's investment adviser or unrated but determined to be of equivalent quality by the fund's investment adviser. The fund's average portfolio duration is generally expected to be less than 2 years, but may be up to 3 years. The fund primarily invests in debt securities denominated in U.S. dollars, including securities issued and guaranteed by the U.S. government, securities of corporate issuers, asset-backed securities (securities backed by assets such as auto loans, credit card receivables or other providers of credit), mortgage-backed securities and debt securities issued by government sponsored entities and federal agencies and instrumentalities that are not backed by the full faith and credit of the U.S. government.The fund may invest up to 5% in debt securities rated BB+ or Ba1 or below, but with a minimum rating of BB- (or Ba3). The fund may also invest in futures contracts and swaps, which are types of derivatives. A derivative is a financial contract, the value of which is based on the value of an underlying financial asset (such as a stock, bond or currency), a reference rate or a market index. The fund may invest in inflation-linked bonds issued by U.S. and non-U.S. governments, their agencies or instrumentalities, and corporations. Inflation-linked bonds are structured to protect against inflation by linking the bond's principal and interest payments to an inflation index, such as the Consumer Price Index for Urban Consumers, so that principal and interest adjust to reflect changes in the index.

Full CGSD Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CGSD vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CGSD vs SCHDCGSD vs JEPICGSD vs OCGSD vs KOCGSD vs MAINCGSD vs JNJCGSD vs ABBVCGSD vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.